You are right too!

PubWeight™: 1.10‹?› | Rank: Top 10%

🔗 View Article (PMC 1180570)

Published in J Clin Invest on August 01, 2005

Authors

Joseph L Witztum1

Author Affiliations

1: Department of Medicine, University of California San Diego, La Jolla, California 92093, USA. jwitztum@ucsd.edu

Articles citing this

Oxidation-specific epitopes are danger-associated molecular patterns recognized by pattern recognition receptors of innate immunity. Circ Res (2011) 2.89

Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol (2011) 2.44

The LDL modification hypothesis of atherogenesis: an update. J Lipid Res (2008) 1.66

Lipoprotein accumulation in macrophages via toll-like receptor-4-dependent fluid phase uptake. Circ Res (2009) 1.63

Divergence of macrophage phagocytic and antimicrobial programs in leprosy. Cell Host Microbe (2009) 1.55

TR4 nuclear receptor functions as a fatty acid sensor to modulate CD36 expression and foam cell formation. Proc Natl Acad Sci U S A (2009) 1.33

CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia. Ann Neurol (2012) 1.27

CD36, a scavenger receptor implicated in atherosclerosis. Exp Mol Med (2014) 1.19

Human oxidation-specific antibodies reduce foam cell formation and atherosclerosis progression. J Am Coll Cardiol (2011) 1.16

The role of oxidized low-density lipoproteins in atherosclerosis: the myths and the facts. Mediators Inflamm (2013) 1.15

The influence of innate and adaptive immune responses on atherosclerosis. Annu Rev Pathol (2013) 1.13

Oxidation-specific epitopes and immunological responses: Translational biotheranostic implications for atherosclerosis. Curr Opin Pharmacol (2013) 1.06

Toll-like receptor-4 and lipoprotein accumulation in macrophages. Trends Cardiovasc Med (2009) 1.01

CD36-dependent 7-ketocholesterol accumulation in macrophages mediates progression of atherosclerosis in response to chronic air pollution exposure. Circ Res (2014) 0.89

Salvianolic acid B inhibits macrophage uptake of modified low density lipoprotein (mLDL) in a scavenger receptor CD36-dependent manner. Atherosclerosis (2012) 0.87

CD36, but not G2A, modulates efferocytosis, inflammation, and fibrosis following bleomycin-induced lung injury. J Lipid Res (2013) 0.82

Dietary carnosine prevents early atherosclerotic lesion formation in apolipoprotein E-null mice. Arterioscler Thromb Vasc Biol (2013) 0.82

Acidification of the intimal fluid: the perfect storm for atherogenesis. J Lipid Res (2014) 0.81

Inflammatory therapeutic targets in coronary atherosclerosis-from molecular biology to clinical application. Front Physiol (2014) 0.81

Deficiency of glycine N-methyltransferase aggravates atherosclerosis in apolipoprotein E-null mice. Mol Med (2012) 0.80

Design and synthesis of a stable oxidized phospholipid mimic with specific binding recognition for macrophage scavenger receptors. J Med Chem (2012) 0.79

CEP Is an Important and Ubiquitous Oxidation Specific Epitope Recognized by Innate Pattern Recognition Receptors. Circ Res (2015) 0.75

Lanatoside C Promotes Foam Cell Formation and Atherosclerosis. Sci Rep (2016) 0.75

Articles cited by this

A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature (1997) 5.55

CD36 is a sensor of diacylglycerides. Nature (2005) 5.20

Targeted disruption of the class B scavenger receptor CD36 protects against atherosclerotic lesion development in mice. J Clin Invest (2000) 5.07

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem (2002) 4.17

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis. Nature (2002) 3.80

Loss of receptor-mediated lipid uptake via scavenger receptor A or CD36 pathways does not ameliorate atherosclerosis in hyperlipidemic mice. J Clin Invest (2005) 3.79

Site specificity of atherosclerosis: site-selective responses to atherosclerotic modulators. Arterioscler Thromb Vasc Biol (2003) 3.35

The macrophage foam cell as a target for therapeutic intervention. Nat Med (2002) 2.98

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem (2002) 2.66

Reduced atherosclerotic lesions in mice deficient for total or macrophage-specific expression of scavenger receptor-A. Arterioscler Thromb Vasc Biol (2000) 2.12

Macropinocytosis is the endocytic pathway that mediates macrophage foam cell formation with native low density lipoprotein. J Biol Chem (2004) 1.92

Increased CD36 protein as a response to defective insulin signaling in macrophages. J Clin Invest (2004) 1.76

Stem cell transplantation reveals that absence of macrophage CD36 is protective against atherosclerosis. Arterioscler Thromb Vasc Biol (2004) 1.74

Secretory sphingomyelinase, a product of the acid sphingomyelinase gene, can hydrolyze atherogenic lipoproteins at neutral pH. Implications for atherosclerotic lesion development. J Biol Chem (1998) 1.68

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes. Arterioscler Thromb Vasc Biol (1998) 1.57

Dual role for scavenger receptor class B, type I on bone marrow-derived cells in atherosclerotic lesion development. Am J Pathol (2004) 1.44

Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors. J Lipid Res (2004) 1.38

Role for sterol regulatory element-binding protein in activation of endothelial cells by phospholipid oxidation products. Circ Res (2004) 1.37

Low density lipoprotein metabolism by human macrophages activated with low density lipoprotein immune complexes. A possible mechanism of foam cell formation. J Exp Med (1988) 1.34

Minimally oxidized low-density lipoprotein increases expression of scavenger receptor A, CD36, and macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol (1998) 1.31

The role of lipoprotein lipase in the metabolism of triglyceride-rich lipoproteins by macrophages. J Biol Chem (1983) 1.30

Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler Thromb (1992) 1.00

Lipoprotein receptors in the vascular wall. Curr Opin Lipidol (2004) 0.99

Role of ABCA1 in cellular cholesterol efflux and reverse cholesterol transport. Arterioscler Thromb Vasc Biol (2003) 0.98

beta-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins. J Neuroinflammation (2004) 0.96